The regulation of these metabolic pathways appears highly dynamic and complex, and it is far from being understood in cancer cells, although some studies propose a role for isoforms of PKM in controlling the balance between G6P routed to PPP and to glycolysis according to the bioenergetic and biosynthetic demands [47, 48]. Here, PKM is linked to cancer.